[HTML][HTML] CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria
D Palacios Araya, KL Palmer, BA Duerkop - PLoS Pathogens, 2021 - journals.plos.org
The rapid emergence of antibiotic-resistant bacteria and the comparatively limited
development of new antibacterial molecules pose a major threat to modern medicine by …
development of new antibacterial molecules pose a major threat to modern medicine by …
[引用][C] CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria.
DP Araya, KL Palmer, BA Duerkop - 2021 - agris.fao.org
CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria. Food
and Agriculture Organization of the United Nations Discover About FAO News Multimedia Main …
and Agriculture Organization of the United Nations Discover About FAO News Multimedia Main …
[PDF][PDF] CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria
D Palacios Araya, KL Palmer, BA Duerkop - PLoS Pathog, 2021 - pdfs.semanticscholar.org
The rapid emergence of antibiotic-resistant bacteria and the comparatively limited
development of new antibacterial molecules pose a major threat to modern medicine by …
development of new antibacterial molecules pose a major threat to modern medicine by …
CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria
DP Araya, KL Palmer, BA Duerkop - PLoS Pathogens, 2021 - search.proquest.com
Toward this goal, clustered regularly interspaced short palindromic repeats/CRISPR-
associated protein (CRISPR/Cas) systems are being explored as possible antimicrobials to …
associated protein (CRISPR/Cas) systems are being explored as possible antimicrobials to …
CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria.
KL Palmer, BA Duerkop - Plos Pathogens, 2021 - europepmc.org
The rapid emergence of antibiotic-resistant bacteria and the comparatively limited
development of new antibacterial molecules pose a major threat to modern medicine by …
development of new antibacterial molecules pose a major threat to modern medicine by …
CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria.
DP Araya, KL Palmer, BA Duerkop - PLoS Pathogens, 2021 - go.gale.com
The rapid emergence of antibiotic-resistant bacteria and the comparatively limited
development of new antibacterial molecules pose a major threat to modern medicine by …
development of new antibacterial molecules pose a major threat to modern medicine by …
[PDF][PDF] CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria
D Palacios Araya, KL Palmer, BA Duerkop - PLoS Pathog, 2021 - journals.plos.org
The rapid emergence of antibiotic-resistant bacteria and the comparatively limited
development of new antibacterial molecules pose a major threat to modern medicine by …
development of new antibacterial molecules pose a major threat to modern medicine by …
CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria.
D Palacios Araya, KL Palmer… - PLoS Pathogens, 2021 - search.ebscohost.com
To determine whether CRISPR/Cas can eradicate all plasmid copies, Tagliaferri and
colleagues used the CRISPR/Cas9 system to target a-lactamase gene in IE i. Cascade …
colleagues used the CRISPR/Cas9 system to target a-lactamase gene in IE i. Cascade …
[HTML][HTML] CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria
DP Araya, KL Palmer, BA Duerkop - PLoS Pathogens, 2021 - ncbi.nlm.nih.gov
The rapid emergence of antibiotic-resistant bacteria and the comparatively limited
development of new antibacterial molecules pose a major threat to modern medicine by …
development of new antibacterial molecules pose a major threat to modern medicine by …
[引用][C] CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria
DP Araya, KL Palmer, BA Duerkop - PLoS pathogens, 2021 - pubmed.ncbi.nlm.nih.gov
CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria
CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria PLoS …
CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria PLoS …